Cargando…
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Current treatments for severe aplastic anemia (SAA) rely on hematopoietic stem cell (HSC) transplantation and immunosuppressive therapies, however these treatments are not always effective. While immune-mediated destruction and inflammation are known drivers of SAA, the underlying mechanisms that le...
Autores principales: | Grazda, Rachel, Seyfried, Allison N., Maddipatti, Krishna Rao, Fredman, Gabrielle, MacNamara, Katherine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002513/ https://www.ncbi.nlm.nih.gov/pubmed/36909559 http://dx.doi.org/10.1101/2023.02.15.528688 |
Ejemplares similares
-
Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1
por: Fredman, Gabrielle, et al.
Publicado: (2011) -
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
por: Smith, Julianne N. P., et al.
Publicado: (2016) -
A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution
por: Libreros, Stephania, et al.
Publicado: (2021) -
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
por: Yurdagul, Arif, et al.
Publicado: (2018) -
Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression
por: McCabe, Amanda, et al.
Publicado: (2018)